Sowell Financial Services LLC Sage Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$54.88 - $79.29 $1,481 - $2,140	-27 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$70.65 - $96.76 $1,907 - $2,612	27 New	27 $2,000
Q4 2020 Jan 13, 2021	SELL	$58.41 - $89.06 $2,102 - $3,206	-36 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $4,935 - $7,494	-120 Reduced 76.92%	36 $2,000
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $4,048 - $6,731	156 New	156 $6,000
Q1 2020 May 12, 2020	SELL	$26.15 - $77.24 $235 - $695	-9 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $1,262 - $1,709	9 New	9 $1,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.